ClearPoint Neuro, Inc.
CLPT
$9.42
-$0.09-0.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 17.48% | -3.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.48% | -3.84% | |||
| Cost of Revenue | 22.85% | -10.88% | |||
| Gross Profit | 14.36% | 0.79% | |||
| SG&A Expenses | 13.31% | 0.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.74% | -5.09% | |||
| Operating Income | 0.59% | 7.11% | |||
| Income Before Tax | -32.28% | -1.22% | |||
| Income Tax Expenses | -50.00% | -68.00% | |||
| Earnings from Continuing Operations | -32.17% | -0.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.17% | -0.93% | |||
| EBIT | 0.59% | 7.11% | |||
| EBITDA | 5.43% | 1.40% | |||
| EPS Basic | -30.26% | -0.29% | |||
| Normalized Basic EPS | -0.23% | -0.62% | |||
| EPS Diluted | -30.26% | -0.29% | |||
| Normalized Diluted EPS | -0.23% | -0.62% | |||
| Average Basic Shares Outstanding | 1.48% | 0.60% | |||
| Average Diluted Shares Outstanding | 1.48% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||